Tilogotamab Antibody
Tilogotamab (GEN-1029) is a hexameric DR5-targeting agonistic complex designed for multiple myeloma research. It engages two distinct DR5 epitopes to induce apoptosis, and its activity has been characterized in both in vitro cell-based assays and in vivo xenograft models of hematological malignancies.
Product Specifications
Product Name Alternative
HexaBody-DR5/DR5, GEN1029, GEN-1029, Hx-DR5-01/05
Target
TNF
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
2.82 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.88 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
